Good morning :)
$
₹
Koninklijke Philips NV ADR

Koninklijke Philips NV ADR

PHG

NYSE
Asset Logo

Koninklijke Philips NV ADR

PHG

NYSE
$26.890.08% (-0.02)
$
₹
$26.890.08% (-0.02)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $25.6B the stock is ranked 533

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

19.57
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.85
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.34
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.75
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

6.31%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

3.86%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 5 analysts reports

Buy
2 analysts
Hold
3 analysts
Sell
0 analyst

Price Upside

+19.08%

Earnings Growth

-3.98%

Rev. Growth

+0.52%

See Detailed Forecast

Company Profile

Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
37.36
37.36
1Y Return
18.86%
18.86%
Buy Reco %
85.71
85.71
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.71
38.71
1Y Return
3.48%
3.48%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
51.76
51.76
1Y Return
17.95%
17.95%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.85
22.85
1Y Return
1.27%
1.27%
Buy Reco %
65.51
65.51
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
30.83
30.83
1Y Return
19.81%
19.81%
Buy Reco %
79.31
79.31
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 19.08% growth, versus a trailing 3-year CAGR of 15.47%.

2026
Current$26.89Baseline
Analyst Target - 1 year
Target$32.02+19.08%

All values in $

202220232024202520262027$18.19$23.87$29.54Target+19.08%
2026
Current$26.89Baseline
Analyst Target - 1 year
Target$32.02+19.08%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 0.52% growth, versus a trailing 3-year CAGR of 0.01%.

2025
Current$17.83Baseline
Forecast for Dec 2026
High$18.13+1.69%
Average$17.92+0.52%
Low$17.84+0.05%

All values in $ Billion

20212022202320242025202617.1517.8218.1618.0217.83Low+0.05%Average+0.52%High+1.69%
2025
Current$17.83Baseline
Forecast for Dec 2026
High$18.13+1.69%
Average$17.92+0.52%
Low$17.84+0.05%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -3.98% growth, versus a trailing 3-year CAGR of 24.36%.

2025
Current$1.82Baseline
Forecast for Dec 2026
High$1.9+4.4%
Average$1.75-3.98%
Low$1.63-10.6%

All values in $

2021202220232024202520261.850.951.241.411.82Low-10.6%Average-3.98%High+4.4%
2025
Current$1.82Baseline
Forecast for Dec 2026
High$1.9+4.4%
Average$1.75-3.98%
Low$1.63-10.6%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

4.3
0.1
5
0.3
3.9
0.1
4.3
0.3
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue4.134.464.375.044.094.334.305.093.904.36
Net Income-0.990.450.18-0.330.070.240.180.390.150.38
Net Profit Margin-24.14%10.10%4.13%-6.64%1.85%5.53%4.27%7.74%3.86%8.80%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Koninklijke Philips NV ADR 19.571.850.75
Abbott Laboratories37.363.501.89
Danaher Corporation38.712.951.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare PHG with any stock or ETF
Compare PHG with any stock or ETF
Comparing from
PHG
ABT
DHR
Loading...

Frequently asked questions

  1. Koninklijke Philips NV ADR (PHG) share price today is $26.89 as of October 24, 2026 at 1:29 AM IST. The stock touched a day high of $26.97 and a day low of $26.64.

  2. Koninklijke Philips NV ADR stock trades on NYSE under the ticker symbol PHG.

  3. Koninklijke Philips NV ADR's market capitalization is $25.63B as of October 24, 2026 at 1:29 AM IST.

  4. Koninklijke Philips NV ADR's price-to-earnings (P/E) ratio is 19.57 as of October 23, 2026.

  5. Koninklijke Philips NV ADR's price-to-book (P/B) ratio is 1.85 as of October 23, 2026.

  6. Yes, Koninklijke Philips NV ADR pays a dividend, with a current dividend yield of 3.86%.

  7. Yes, You can buy Koninklijke Philips NV ADR shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Koninklijke Philips NV ADR shares in three steps: 1. Search Koninklijke Philips NV ADR on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Koninklijke Philips NV ADR trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Koninklijke Philips NV ADR (PHG) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3717 shares at the current price of $26.89.

Loading...